Jacobi Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Jacobi Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-42	Closed	-$9K	–	1456
2021 Q1	$9K	Hold	42	–	–	﹤0.01%	1016
2020 Q4	$5K	Hold	42	–	–	﹤0.01%	1027
2020 Q3	$4K	Hold	42	–	–	﹤0.01%	1012
2020 Q2	$5K	Hold	42	–	–	﹤0.01%	933
2020 Q1	$4K	Hold	42	–	–	﹤0.01%	883
2019 Q4	$4K	Buy	42 +22	+110%	+$2.47K	﹤0.01%	898
2019 Q3	$2K	Hold	20	–	–	﹤0.01%	971
2019 Q2	$3K	Buy	+20	New	+$3.46K	﹤0.01%	911
2018 Q4	–	Sell	-20	Closed	-$3K	–	1021
2018 Q3	$3K	Hold	20	–	–	﹤0.01%	874
2018 Q2	$3K	Buy	+20	New	+$2.84K	﹤0.01%	909

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Jacobi Capital Management's GWPH Position: Q2 2021 in Review

Jacobi Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 42 shares — an estimated $9K sold.

Jacobi Capital Management first reported a position in GWPH in Q2 2018 and held it in 10 quarters. The position peaked at $9K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Jacobi Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Jacobi Capital Management sold 42 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $9K.
Jacobi Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 10 quarters.
Jacobi Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Jacobi Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.